@ent3c I read this as a solution for unlivable-in-the-US salaries following years of training in $24k-40k roles to pass licensure exams for the profession as a whole with high student loan debt to income ratio (3:1) and society’s general stigma of therapy but love of coaching.
A collection in honour of Bill Hill including his work published in Heredity over the past 50 years, along with papers published in Heredity in the past two years that have cited some of his seminal work.
https://t.co/JUQNiGoOwd
#popgen#quantgen@GenSocUK
Taylor Swift has 87.3 million followers on Twitter - the exact same number as Trump.
This is the first campaign ad she has ever given permission to use her music.
#onlytheyoung
@cathrynlewis@mja@PGCgenetics Seconding this -- Mark’s thoughtfulness, work ethic & calm organizational shepherding of the data is invaluable. Always been my friend & mentor & spotted these traits (& his talent for posing good questions that can be tested!) the day I met him in 2010. ⭐️ treat to work with
Odile Crick, my grandmother, drew the first published diagram of #DNA
It was 65 years ago #onthisday, as a diagram in the first of the three papers published in @nature on the structure of DNA. ( Watson & Crick, Wilkins et al, Franklin & Gosling)
#SciArt ✨ #Scicomm#DNADay
THREAD: Since she’s about to close out #Dros18, I want to talk about @TingWu_Lab and Ting’s personal impact on me and the greater scientific community because informal mentors are incredibly important and she’s one of the best. 1/10
Wray (@WrayNaomi) #GBD18: Suggests investing in reference samples (like gene expression) for integration with GWAS results. Wants more samples collected with more phenotype information.
In 60 secs @WrayNaomi clears up confusion about additivity, epistasis and polygenicity. Additive effects measured at population level, epistatic effects apparent at individual level. #GBD18
Brennand #GBD18: hiPSC NPCs and cancer cell line drug signatures differed in genes associated with SCZ via common and rare variation.
Take home from this early work: if you are going to do a drug screen, do it in the right cells.
Webber #GBD18: Three cases vs three controls — single cell sequencing. Disaster 1: three plates failed and so only 26% of cells passed QC. Disaster 2: one of the cases had a different condition. But still had 50 patient cells that were deeply sequenced.
Stefánsson #GBD18: When sequencing genomes of individuals from Iceland, found on average 65 de novo variants, which means 1 in 10 individuals have a de novo LoF. Highlights that this means ~1/20 have a de novo LoF in a gene expressed in the brain.
https://t.co/T3Mzo0e8ep